T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.96B |
| 3 |
Global Payments
GPN
|
+$1.95B |
| 4 |
Salesforce
CRM
|
+$1.48B |
| 5 |
Boeing
BA
|
+$1.47B |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.45B |
| 5 |
Pfizer
PFE
|
+$1.22B |
Sector Composition
| 1 | Technology | 19.69% |
| 2 | Healthcare | 15.84% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Worthington Enterprises
WOR
$3.17B
| $15.1M | ﹤0.01% |
679,495
-7,347
| -1% | -$163K |
|
1227
RGC Resources
RGCO
$225M
| $15M | ﹤0.01% |
512,841
+1,502
| +0.3% | +$43.9K |
|
1228
DXC Technology
DXC
$2.51B
| $14.8M | ﹤0.01% |
500,057
+6,457
| +1% | +$190K |
|
1229
NOV
NOV
$4.79B
| $14.7M | ﹤0.01% |
695,334
+2,801
| +0.4% | +$59.4K |
|
1230
Zions Bancorporation
ZION
$8.62B
| $14.7M | ﹤0.01% |
329,670
-787
| -0.2% | -$35K |
|
|
IGMS
1231
DELISTED
IGM Biosciences
IGMS
| $14.5M | ﹤0.01% |
+815,279
| New | +$14.5M |
|
1232
Axsome Therapeutics
AXSM
$5.91B
| $14.3M | ﹤0.01% |
708,871
+130,012
| +22% | +$2.63M |
|
|
AUTL
1233
Autolus Therapeutics
AUTL
$367M
| $14.3M | ﹤0.01% |
1,149,729
-30,667
| -3% | -$381K |
|
1234
Newell Brands
NWL
$2.48B
| $14.2M | ﹤0.01% |
757,863
-19,596
| -3% | -$367K |
|
|
WW
1235
DELISTED
WW International
WW
| $14.1M | ﹤0.01% |
373,071
-9,118
| -2% | -$345K |
|
1236
BorgWarner
BWA
$9.46B
| $14.1M | ﹤0.01% |
435,496
+271
| +0.1% | +$8.75K |
|
|
PROS
1237
DELISTED
ProSight Global, Inc.
PROS
| $13.9M | ﹤0.01% |
+716,698
| New | +$13.9M |
|
1238
uniQure
QURE
$904M
| $13.7M | ﹤0.01% |
347,096
+908
| +0.3% | +$35.7K |
|
1239
Q2 Holdings
QTWO
$5.13B
| $13.6M | ﹤0.01% |
172,704
-343,213
| -67% | -$27.1M |
|
1240
AMN Healthcare
AMN
$699M
| $13.5M | ﹤0.01% |
235,203
+195,246
| +489% | +$11.2M |
|
1241
Albemarle
ALB
$8.94B
| $13.4M | ﹤0.01% |
192,535
-11,407
| -6% | -$793K |
|
1242
Copa Holdings
CPA
$4.86B
| $13.2M | ﹤0.01% |
133,421
+5,701
| +4% | +$563K |
|
1243
Phibro Animal Health
PAHC
$1.61B
| $13.1M | ﹤0.01% |
614,089
+1,625
| +0.3% | +$34.7K |
|
1244
The Mosaic Company
MOS
$10.7B
| $13.1M | ﹤0.01% |
638,353
+1,050
| +0.2% | +$21.5K |
|
1245
Resideo Technologies
REZI
$5.66B
| $12.9M | ﹤0.01% |
900,469
-667,661
| -43% | -$9.58M |
|
1246
Invesco
IVZ
$10B
| $12.9M | ﹤0.01% |
761,597
-5,070
| -0.7% | -$85.9K |
|
|
ICPT
1247
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.8M | ﹤0.01% |
193,179
-1,394
| -0.7% | -$92.5K |
|
|
MGP
1248
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $12.8M | ﹤0.01% |
426,569
+84,126
| +25% | +$2.53M |
|
1249
iShares MSCI India ETF
INDA
$9.38B
| $12.7M | ﹤0.01% |
378,700
| – | – |
|
1250
Moderna
MRNA
$9.15B
| $12.7M | ﹤0.01% |
795,011
-40,416
| -5% | -$643K |
|